In a Forbes.com article, Steve Denning explains why the practice of massive share buybacks among public companies is like “snorting corporate cocaine.”
In a Forbes.com article, Steve Denning explains why the practice of massive share buybacks among public companies is like “snorting corporate cocaine.”